Showing 1,523 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

UK health services

London HIV drug prescribing changes – patient satisfaction and clinical outcomes maintained

News
22 April 2013
HIV treatment

Shortages of new one-a-day ARV pills in South Africa

Editor's pick
IRIN
22 April 2013
New & experimental HIV treatments

New nanotechnique to deliver life-saving drugs to the brain

Editor's pick
Phys.org
22 April 2013
New & experimental hepatitis C treatment

Roche to commercialize Hepatitis C drug in China with Ascletis

Editor's pick
Yahoo! News
15 April 2013
Access to healthcare

Roadmap: The HIV Drug Pipeline and its Patents

Editor's pick
Initiative for Medicines Access and Knowledge (I-MAK)
11 April 2013
Generic medicines

Preparing for Generics: The push for affordable HIV treatment doesn’t end with patent expirations

Editor's pick
Treatment Action Group
11 April 2013
Pharmaceutical industry

South Africa rolls out new single dose AIDS drug

Editor's pick
France 24
10 April 2013
Harm reduction

Big Pharma Company Jacks Up Price of Overdose Live Saver by 1100%: Now, More People Will Die

Editor's pick
AlterNet
9 April 2013
New & experimental hepatitis C treatment

Gilead Submits New Drug Application to U.S. FDA for Sofosbuvir for the Treatment of Hepatitis C

Editor's pick
Gilead press release
9 April 2013
Access to healthcare

The Judgment In Novartis v. India: What The Supreme Court Of India Said

Editor's pick
Intellectual Property Watch
8 April 2013
Access to healthcare

Debunking pharma's cant against the Novartis judgment: myth and fact

Editor's pick
EATG
8 April 2013
Clinical trials

Big pharma, big data

Editor's pick
Financial Times
5 April 2013
New & experimental HIV treatments

DFH Pharma, USA Partners with Hetero Group, INDIA to Develop 2nd Generation HIV Maturation Inhibitor Drugs

Editor's pick
DFH Pharma press release
4 April 2013
Pharmaceutical industry

Analysis: Big Pharma down, not out, after Indian patent blow

Editor's pick
Reuters
3 April 2013
Pharmaceutical industry

India’s drug patent rejection shows emerging markets not lucrative, could bring cutbacks there

Editor's pick
Washington Post
3 April 2013
Pharmaceutical industry

India dismisses antitrust complaint against Gilead Sciences

Editor's pick
Intellectual Property Watch
3 April 2013
Access to healthcare

Novartis denied cancer drug patent in landmark Indian case

Editor's pick
The Guardian
2 April 2013
Access to healthcare

Novartis Loses Patent Bid: Lessons From India’s 3(d) Experience

Editor's pick
Intellectual Property Watch
2 April 2013
New & experimental hepatitis C treatment

Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C

Editor's pick
Janssen press release
2 April 2013
Access to healthcare

Indonesia to override patents for live-saving medicines

Editor's pick
http://www.plusnews.org/Report/97728/Indonesia-to-override-patents-for-live-saving-medicines
26 March 2013
Access to healthcare

Shasun Signs Licence With MPP to Produce Low-Cost HIV Medicines

Editor's pick
Medicines Patent Pool
25 March 2013
New & experimental HIV treatments

European CHMP Adopts Positive Opinion for Stribild®, a Once-Daily, Integrase Inhibitor-Based, Single Tablet Regimen for the Treatment of HIV-1 Infection

Editor's pick
Gilead press release
22 March 2013
Side effects

EU new drug approval studies "have too few patients to evaluate safety"

Editor's pick
Pharma Times
22 March 2013
Hepatitis C treatment

Roche’s Pegasys receives EU approval for the treatment of chronic hepatitis C in children five years of age and older

Editor's pick
Roche press release
19 March 2013